Austar Lifesciences Limited (HKG:6118)
Hong Kong · Delayed Price · Currency is HKD 0.9200
+0.0200 (2.22%)
Jan 21, 2026, 4:08 PM HKT
Austar Lifesciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 35.2 | 16.08 | -113.47 | 87.46 | 277.3 | 33.1 | Upgrade |
Depreciation & Amortization | 47.15 | 47.46 | 39.63 | 33.81 | 29.62 | 29.84 | Upgrade |
Other Amortization | 6.53 | 6.16 | 5.92 | 3.2 | 2.35 | 1.96 | Upgrade |
Loss (Gain) From Sale of Assets | 0.2 | 0.2 | -4.1 | 0.3 | 0.72 | 0.05 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | 1.09 | 3.14 | Upgrade |
Loss (Gain) From Sale of Investments | 3.81 | 3.81 | 31.89 | -3.21 | 6.24 | 12.14 | Upgrade |
Loss (Gain) on Equity Investments | -0.3 | -0.3 | -6.73 | -9.54 | -209.65 | -10.48 | Upgrade |
Other Operating Activities | 1.61 | 1.36 | 97.08 | 28.66 | 44.69 | 3.79 | Upgrade |
Change in Accounts Receivable | 35.7 | 35.7 | -39.46 | -299.98 | -259.11 | 6.58 | Upgrade |
Change in Inventory | 10.87 | 10.87 | 85.55 | 32.04 | -222.69 | -47.27 | Upgrade |
Change in Accounts Payable | -36.54 | -36.54 | -74.97 | 103.01 | 124.87 | -41.68 | Upgrade |
Change in Unearned Revenue | 17.44 | 17.44 | -200.8 | -83.33 | 145.51 | 100.2 | Upgrade |
Change in Other Net Operating Assets | -3.44 | -3.44 | 104.6 | 68.46 | -44.39 | -39.15 | Upgrade |
Operating Cash Flow | 118.23 | 98.81 | -62.65 | -37.93 | -103.45 | 52.22 | Upgrade |
Operating Cash Flow Growth | 444.35% | - | - | - | - | 38.18% | Upgrade |
Capital Expenditures | -26.2 | -20.49 | -69.24 | -117.11 | -100.57 | -26.54 | Upgrade |
Sale of Property, Plant & Equipment | 1.98 | 2.07 | 0.17 | 0.05 | 0.17 | 0.24 | Upgrade |
Cash Acquisitions | 2.82 | 2.82 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | 2.86 | -2.59 | -1.71 | -19.33 | -15.31 | -40.68 | Upgrade |
Investment in Securities | -1 | 9 | 4.51 | -21.86 | 164.26 | 0.05 | Upgrade |
Other Investing Activities | 8.86 | 13.63 | 11.8 | 5.1 | 16.47 | 7.13 | Upgrade |
Investing Cash Flow | -10.68 | 4.43 | -54.47 | -153.14 | 65.02 | -59.81 | Upgrade |
Long-Term Debt Issued | - | 303.14 | 442.36 | 246.88 | 109.1 | 45 | Upgrade |
Total Debt Issued | 319.4 | 303.14 | 442.36 | 246.88 | 109.1 | 45 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -0.15 | Upgrade |
Long-Term Debt Repaid | - | -387.56 | -271.76 | -116.39 | -45.35 | -47.57 | Upgrade |
Total Debt Repaid | -388.32 | -387.56 | -271.76 | -116.39 | -45.35 | -47.72 | Upgrade |
Net Debt Issued (Repaid) | -68.92 | -84.43 | 170.6 | 130.49 | 63.75 | -2.72 | Upgrade |
Other Financing Activities | -14.6 | -16.9 | -23.49 | -5.19 | -4.4 | -2.79 | Upgrade |
Financing Cash Flow | -83.52 | -101.32 | 147.12 | 125.3 | 59.35 | -5.51 | Upgrade |
Foreign Exchange Rate Adjustments | 0.65 | 1.13 | 0.14 | 0.95 | -0.42 | -0.04 | Upgrade |
Net Cash Flow | 24.68 | 3.04 | 30.14 | -64.82 | 20.5 | -13.14 | Upgrade |
Free Cash Flow | 92.04 | 78.31 | -131.88 | -155.04 | -204.02 | 25.68 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | 6.71% | Upgrade |
Free Cash Flow Margin | 6.30% | 5.22% | -7.48% | -7.19% | -10.13% | 1.98% | Upgrade |
Free Cash Flow Per Share | 0.18 | 0.15 | -0.26 | -0.30 | -0.40 | 0.05 | Upgrade |
Cash Interest Paid | 14.6 | 17.15 | 13.86 | 9.36 | 4.4 | 2.79 | Upgrade |
Cash Income Tax Paid | 7.96 | 6.88 | 7.4 | 15.69 | 7.81 | 5.6 | Upgrade |
Levered Free Cash Flow | 90.33 | 56.33 | -88.74 | -182.04 | -237.32 | -33.74 | Upgrade |
Unlevered Free Cash Flow | 99.36 | 66.97 | -80.01 | -176.04 | -234.56 | -32 | Upgrade |
Change in Working Capital | 24.03 | 24.03 | -125.07 | -179.81 | -255.8 | -21.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.